Transport a 62-year-old male with cardiogenic shock on an IABP following failed PCI. Complete pre-transport IABP checklist, troubleshoot augmentation alarms, manage acute limb ischemia, and maintain hemodynamic stability throughout a 42-minute flight.
Dispatch: "MedFlight 4, inter-facility transport. Transferring: Referring Hospital Cath Lab. Receiving: receiving cardiac center. Patient is a 62-year-old male, post-STEMI with cardiogenic shock, on intra-aortic balloon pump (IABP). Interventional cardiologist requests urgent transfer for LVAD evaluation. Flight time: 42 minutes."
Transferring Cardiologist Report:
- Patient: 62 y/o male, 90 kg, PMHx: HTN, DM2, hyperlipidemia, 40 pack-year smoker
- Presentation: Anterior STEMI, Killip Class IV (cardiogenic shock), PCI attempted but LAD 100% occlusion — failed revascularization, TIMI 0 flow
- IABP: transport-compatible IABP console, 40 mL balloon, 1:1 augmentation, positioned correctly (CXR confirmed — tip approximately 2 cm above the carina, below the left subclavian origin, confirmed on the pre-transfer chest X-ray)
- Vitals: HR 108 (sinus tach), Unaugmented BP 88/62 (estimated MAP 71 mmHg), SpO2 94% on 6L NC, RR 22
- Hemodynamics: CI 1.6 L/min/m² (cardiogenic shock <2.0), PCWP 28 mmHg, SVR 1,840
- Medications: Norepinephrine 0.08 mcg/kg/min, heparin 1,200 units/hr (ACT 220; the cardiologist’s patient-specific target is 200–250 seconds), dobutamine 5 mcg/kg/min
- Access: Right femoral arterial line (IABP), left femoral venous sheath, right IJ triple-lumen CVC, 18g left AC
Cardiologist: "The balloon is running on the bedside monitor. Your transport team needs to manage the IABP in flight. He's on 3 drips. If the balloon stops, he'll crash."
Your assessment:
Airway: Patent, speaking in short sentences, no stridor
Breathing: RR 22, SpO2 94% on 6L NC, bibasilar crackles (pulmonary edema)
Circulation: HR 108 sinus tach, unaugmented BP 88/62 (estimated MAP 71 mmHg); reported assisted pressure pair 108/72 requires waveform confirmation. A conventional 108/72 pressure pair gives estimated MAP 84 mmHg, not 71; assess IABP mean pressure from the integrated waveform, skin pale/cool/diaphoretic, cap refill 4 sec
Disability: Alert, anxious, oriented x3, GCS 15
Lines: Right femoral IABP, left femoral venous sheath, right IJ CVC, left AC 18g
IABP Assessment:
- Balloon catheter: 40 mL, 1:1 ratio (augments every beat)
- Trigger mode: ECG with an adequate R-wave; another trigger may be needed if the ECG is unreliable, with timing verified against the arterial waveform
- Augmentation waveform: Diastolic augmentation 108 mmHg, assisted systolic 88 mmHg ✓
- Helium tank: 85% full; verify manufacturer reserve requirements, battery runtime and expected transport time including delays
- Console: Transport-compatible console; fully charged battery and backup power plan verified
Key IABP transport rules:
1. Keep patient supine — NO hip flexion >30° (kinks catheter)
2. Maintain this patient’s ordered heparin unless the treating team changes it; anticoagulation targets are individualized
3. Monitor insertion-side limb perfusion (right leg — check pulses q15 min), left radial pulse and left arm perfusion
4. Helium tank level must be checked before transport
5. Choose a reliable trigger and verify inflation/deflation timing. Pressure triggering is an option in a regular rhythm when the ECG signal is inadequate
Right foot: Warm, DP pulse 2+ ✓ (no limb ischemia currently)
You are preparing to move the patient to the helicopter, and the IABP console must go with him. He is alert and anxious with bibasilar crackles, SpO₂ 94% on 6 L nasal cannula, HR 108 and unaugmented BP 88/62. The balloon runs 1:1 on ECG trigger, the helium tank reads 85%, and the right foot is warm with a 2+ DP pulse. Norepinephrine, dobutamine and heparin are running.
What is your most important pre-transport check?
Choose your answer to see the feedback. The rest of the case, the scored debrief and the Virtual FTO review come with a subscription.
Written and reviewed by Chester Shermer, MD, FACEP, board-certified emergency physician and HEMS medical director.